Found 33 matching trials
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor PHASE2 The purpose of this research study is to see how useful it is to look at bi...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma PHASE2 This phase II trial tests how well niraparib and dostarlimab work in treati...
Show More Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment PHASE3 Randomized phase 3 trial evaluating niraparib plus dostarlimab vs chemother...
Show More Location
Azienda Ospedaliera Spedali Civili
Learn More & Join Trial
Improving Public Cancer Care by Implementing Precision Medicine in Norway PHASE2 IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Show More Location
Sykehuset Ålesund
Learn More & Join Trial
Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer PHASE3 ENGOT-OV42 / NSGO-AVATAR: This three-arm randomized trial is to demonstrate...
Show More Learn More & Join Trial
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib PHASE2 Carcinosarcomas (CS) (malignant mixed Müllerian tumors) are highly aggressi...
Show More Learn More & Join Trial
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer PHASE3 Ovarian cancer is a heterogeneous disease, characterized by complex molecul...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants PHASE2 This is a multicenter, open-label, phase 2 study to evaluate the efficacy a...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas PHASE2 This phase II trial studies the effect of niraparib and dostarlimab in trea...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
UNITO-001- Study in HRR/PDL1 Positive MPM/NSCLC PHASE2 This is a single arm, prospective, interventional, multicenter phase 2 stud...
Show More Location
AOU San Luigi- Department of Oncology
Learn More & Join Trial